Implications of CooperCompanies' results EQUITY: JAPAN MEDICAL TECHNOLOGIES Strong sales of contact lenses used to suppress myopia progression in Japan Quick Note By region, underlying sales growth (ex forex effects) at CooperVision (contact lenses segment) turned negative y-y in APAC in 25/10 Q3 (May–Jul 2025). Management expects sales growth to return to around the market average by Q4 (Aug–Oct) and be in line with the market average throughout 27/10. In Japan, MiSight 1 day, which went on sale in Februar ...